DNTH vs VFC · rev $6.2M vs P/E 26, rev $9.50B
Dianthus Therapeutics Inc. (DNTH) versus VF Corporation (VFC) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
VF Corporation (VFC) is a apparel manufacturing company listed on NYSE.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported VFC revenue for 2025-03-29 was $9.50B. Net income was -$189.7M. Revenue was down 4.1% from 2024-03-30 to 2025-03-29. VFC currently screens at market cap $6.55B and trailing P/E 26.1.
DNTH currently screens at market cap $4.40B. VFC currently screens at market cap $6.55B and trailing P/E 26.1.
Not investment advice. Open the DNTH and VFC stock pages for the full models.
Not investment advice.